HROW Harrow, Inc.
HROW Harrow, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bear converging
POC $39.16 · VWAP $39.02 · -27.1% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
HROW Price Structure
Loading timeframes…
Peers
Every watchlist HROW belongs to, members best 30-day change first — HROW highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@healthcare
Harrow furnished its earnings release to the SEC on August 10, 2026 (8-K, Item 2.02) and filed its 10-Q for the quarter ended June 30, 2026 the same day. No figures from these filings are recorded here.
full note →Against street estimates
How HROW's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about HROW from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 20 days ago · Oct 3
- HROW - Harrow Inc Earnings Reports, Summaries & Call Transcripts | Morningstar
- Imprimis Stock Price Today | NASDAQ: HROW Live - Investing.com
- HROW | Imprimis Share Price - Investing.com NG
- Harrow Announces Second Quarter 2026 Financial Results | Harrow, Inc.
- Harrow (HROW) Stock Price, Quote, News & History | Benzinga
HROW research tape
45 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.